本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Trevi Therapeutics Inc.

7.89
+0.890012.71%
盘后7.83-0.0600-0.76%19:59 EDT
成交量:373.05万
成交额:2,853.04万
市值:9.40亿
市盈率:-17.75
高:8.11
开:7.05
低:7.00
收:7.00
数据加载中...
2022/05/09

SEC问询函

CORRESP [Cover] - Correspondence
2022/05/02

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/04/25

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/04/21

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/21

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/18

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/07

重要事件披露

8-K - Current report
2022/03/17

重要事件披露

8-K - Current report
2022/03/17

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/16

重要事件披露

8-K - Current report
2022/03/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/24

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/01

重要事件披露

8-K - Current report
2022/01/26

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/14

重要事件披露

8-K - Current report
2022/01/05

重要事件披露

8-K - Current report